(S)-Mephenytoin has been researched along with furafylline in 1 studies
| Studies ((S)-Mephenytoin) | Trials ((S)-Mephenytoin) | Recent Studies (post-2010) ((S)-Mephenytoin) | Studies (furafylline) | Trials (furafylline) | Recent Studies (post-2010) (furafylline) |
|---|---|---|---|---|---|
| 13 | 0 | 11 | 121 | 2 | 42 |
| Protein | Taxonomy | (S)-Mephenytoin (IC50) | furafylline (IC50) |
|---|---|---|---|
| Cytochrome P450 1A2 | Homo sapiens (human) | 2.5292 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, R; Liu, Y; She, M; Wu, Z | 1 |
1 other study(ies) available for (S)-Mephenytoin and furafylline
| Article | Year |
|---|---|
The inhibition study of human UDP-glucuronosyltransferases with cytochrome P450 selective substrates and inhibitors.
Topics: Cytochrome P-450 Enzyme Inhibitors; Enzyme Activation; Enzyme Inhibitors; Glucuronosyltransferase; Humans; Molecular Structure; Recombinant Proteins; Stereoisomerism; Structure-Activity Relationship; Substrate Specificity | 2011 |